The Valley Desk

NCT01449929 · Interventional trial

Dolutegravir Compared to Darunavir/Ritonavir , Each in Combination With Dual Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in ART-naive Subjects

Overall registry status Completed

Phase 3

Conditions Infection, Human Immunodeficiency Virus

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov